Escaping BCR-ABL-induced IRF8 suppression in stem cells controls immune surveillance in CML

被引：0
|
作者：
Inselmann, S. [1 ]
Wang, Y. [1 ]
Ernst, T. [2 ]
Liebler, S. [1 ]
Hochhaus, A.
Brendel, C. [1 ]
Neubauer, A. [1 ]
Burchert, A. [1 ]
机构：
[1] Univ Klinikum Giessen & Marburg, Marburg, Germany
[2] Univ Klin Jena, Jena, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V930
引用
收藏
页码：307 / 307
页数：1
相关论文
共 25 条
  • [21] Activity of the farnesyl transferase inhibitor SCH66336 against BCR-ABL-induced murine leukemia, STI571-resistant CML cell lines, and primary cells from CML patients.
    Peters, DG
    Hoover, RR
    Koh, EY
    Zhane, HY
    Mahon, FX
    Melo, JV
    Kirschmeier, P
    Bishop, WR
    Daley, GQ
    BLOOD, 2000, 96 (11) : 510A - 510A
  • [22] Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs
    Stella, Stefania
    Tirro, Elena
    Conte, Enrico
    Stagno, Fabio
    Di Raimondo, Francesco
    Manzella, Livia
    Vigneri, Paolo
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (06) : 1085 - 1098
  • [23] Implication of STAT-5 Recruitment in the Expression of IRF-8 and in the Impairment of Human Plasmacytoid Dendritic Cells Differentiation Induced by BCR-ABL and GM-CSF
    Barra, Anne
    Brault, Lucie
    Turhan, Ali G.
    Roy, Lydia
    Guilhot, Frangois
    Gombert, Jean-Marc
    BLOOD, 2008, 112 (11) : 1097 - 1097
  • [24] Bcr-Abl Impairs T Cell Development From Murine Induced Pluripotent Stem Cells and Hematopoietic Stem Cells; A Partial Explanation for the Concept That Ph plus Clone Never Involves T Cell Lineage in CML
    Chanda, Bidisha
    Izawa, Kiyoko
    Harnprasopwat, Ratanakanit
    Takahashi, Keisuke
    Kobayashi, Seiichiro
    Kanegae, Yumi
    Saito, Izumu
    Tojo, Arinobu
    BLOOD, 2011, 118 (21) : 1600 - 1600
  • [25] A highly sensitive RT-PCR assay for interferon-γ identifies multiple circulating low frequency CD8+ T cells recognizing tumor peptides PR1, WT1 and BCR-ABL in normal individuals, CML patients and stem cell transplant (SCT) recipients.
    Rezvani, K
    Grube, M
    Hensel, N
    Fujiwara, H
    Sconocchia, G
    Barrett, J
    BLOOD, 2002, 100 (11) : 410B - 410B
123